Main Catalog

Found 81
Sort by
AMCP Annual Meeting
Member Free
Non-Member $30.00

Patient Review and Restriction Programs: Prescription Drug Monitoring Programs and the Need for Collaboration

Contact Hours: 1.25. Patient Review and Restriction (PRR) programs are commonly used by health plans in doctor’s offices to manage the excessive prescribing of controlled substances or services.
Hospital/Health Systems
AMCP Annual Meeting
Member Free
Non-Member $30.00

Patient-Reported Outcomes: A Primer for Managed Care Pharmacists

Contact Hours: 1.25. Participants should claim continuing pharmacy education (CPE) credit for this home study activity, only if they have not claimed credit for the live activity presented at AMCP Annual Meeting 2017.
Patient Care
Nexus Conferences
Member Free
Non-Member $30.00

Payer & Manufacturer Communications: What’s Changed & How Does it Impact Managed Care Pharmacy? - Nexus 2017

Contact Hours: 1.5. FDA released long-awaited draft guidance clarifying the Provisions of FDAMA 114 as updated by Cures 3037, and also outlined its current thinking around preapproval information exchange (PIE).
CMS
AMCP Annual Meeting
Member $15.00
Non-Member $30.00

Perspectives in Gene Therapy Management - Annual Meeting 2019

Contact Hours: 1.0. The potential for gene therapy to transform the treatment of a wide variety of health conditions has important implications for many stakeholders.
Gene Therapy
AMCP Annual Meeting
Member Free
Non-Member $30.00

Pharmacy Benefit Management—Staying Ahead of Your Competition

Contact Hours: 1.25. Consolidations, acquisitions and partnerships across the health care spectrum have led to a highly competitive pharmacy benefit management (PBM) market.
Pharmacy Benefit Design
Nexus Conferences
Member $15.00
Non-Member $30.00

Preventative Treatment for Alzheimer’s Disease and the Future Role of Value-Based Payment Arrangements

Contact Hours: 1.5. The current understanding of Alzheimer’s disease is evolving.
Alzheimer's
AMCP Annual Meeting
Member $15.00
Non-Member $30.00

Pulmonary Arterial Hypertension and the Managed Care Considerations for Formulary Decision-Making

Contact Hours: 1.25. Patients with pulmonary arterial hypertension (PAH) currently have a 60% five-year survival outlook, which has been increasing since the 1980s when it was a 37% five-year outlook.
Pulmonary Arterial Hypertension
Nexus Conferences
Member Free
Non-Member $30.00

Rare Disease Therapies: Management Strategies to Pipeline Implications for Health Plans - Nexus 2017

Contact Hours: 1.5. The drug pipeline contains over 560 therapies in development for rare diseases.
Orphan Disease
Nexus Conferences
Member $15.00
Non-Member $30.00

Real-Time Pharmacy Benefits: Results and Learnings from a Real-World Implementation

Contact Hours: 1.5. Real-time pharmacy benefits (RTPB) deliver real-time access to medication pricing and restriction information at the point of prescribing.
Real-TIme Pharmacy
AMCP Annual Meeting
Member Free
Non-Member $30.00

Real-World Experience Managing Orphan Drugs Across Pharmacy and Medical Benefits

Contact Hours: 1.25. Recently approved drugs for orphan diseases have annual costs ranging from $90,000 to over $1 million, while also having variable value propositions.
Orphan Disease